8 reports

R& D Progress Research and Development Brief PD-## Product Description VACCINE FOR ALLERGIC RHINITIS AND ASTHMA Product Description The vaccine candidate is under development for the development for the treatment of allergic rhinitis and asthma.

  • Cholesterol
  • Vaccine
  • World
  • Company Operations
  • AFFiRiS AG

Sandoz Generic Advair Diskus®regulatory submission was accepted by FDA for treatment of asthma and airflow obstruction and reducing exacerbations in patients with COPD.

  • Cholesterol
  • Clinical Trial
  • Diagnostics
  • United States
  • GlobalData's company

ITS KETAS IS A PHOSPHODIESTERASE INHIBITOR AGENT FOR AMELIORATING BRONCHIAL ASTHMA AND CEREBRO-VASCULAR DISORDERS.

  • Cholesterol
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

About LIPO-## LIPO-## is an injectable formulation of salmeterol xinafoate, a well-known long-acting ß##-adrenergic receptor agonist used in several FDA-approved drugs, including ADVAIR for asthma.

  • Cholesterol
  • Obesity
  • World
  • Product Initiative
  • Neothetics, Inc.
  • DYSLIPIDEMIA - PIPELINE BY KYORIN PHARMACEUTICAL CO LTD, H1 2018
  • DYSLIPIDEMIA - PIPELINE BY KUHNIL PHARMACEUTICAL CO LTD, H1 2018

Its ketas product is a phosphodiesterase inhibitor agent for ameliorating bronchial asthma and cerebro-vascular disorders.

  • Cardiovascular Disease
  • Cholesterol
  • Chronic Disease
  • Pharmaceutical
  • Amarin Corporation plc
  • DYSLIPIDEMIA - PIPELINE BY KYORIN PHARMACEUTICAL CO LTD, H2 2018
  • DYSLIPIDEMIA - PIPELINE BY KUHNIL PHARMACEUTICAL CO LTD, H2 2018

It is also developing new approaches to the treatment of asthma.

  • Cholesterol
  • Chronic Disease
  • United States
  • Product Initiative
  • Amarin Corporation plc

" Atopic dermatitis represents a significant unmet medical need, with a health-related quality of life impact exceeding that of asthma, epilepsy and diabetes.

  • Cholesterol
  • United States
  • Company Operations
  • Product Initiative
  • Vitae Pharmaceuticals, Inc.

The company' s KETAS is a phosphodiesterase inhibitor agent for ameliorating bronchial asthma and cerebro-vascular disorders.

  • Cholesterol
  • Pharmaceutical
  • United States
  • Product Initiative
  • Acasti Pharma Inc.